Court Dismisses Mark Midei's Defamation Suit

Shelley Wood

April 24, 2012

April 24, 2012 (Batimore, Maryland) — The Baltimore Sun is reporting that Dr Mark Midei's defamation suit against St Joseph Medical Center has been dismissed by the Baltimore County Circuit Court [1].

Contacted last night by heartwire , Midei said he and his lawyers had not yet seen the court's opinion and only heard of the court's decision when the Sun called asking for a statement.

As previously reported by heartwire , Midei lost his medical license in July 2011 after the Maryland Medical Board concluded a review of alleged unnecessary stent implantations by Midei, ultimately concluding that his violations of the Medical Practice Act were "repeated and serious." Midei is also being sued by patients treated in some of the cases investigated.

Midei himself, however, had been trying to sue St Joseph Medical Center (SJMC) and its umbrella company, Catholic Health Initiatives Inc, on counts of fraud; invasion of privacy/false light; intentional infliction of emotional distress; and interference with economic relations. At the heart of the lawsuit was the hospital's decision to send letters to patients to tell them they may have not needed their stents before actually reviewing individual cases, according to Midei's suit.

In the suit, Midei accused St Joseph with waging "an epic campaign of corporate deception, trickery, and fraud that has resulted in [his] complete destruction." In over 52 pages, the suit traced the allegedly profit-motivated actions by the hospital and its parent company against Midei, part of which he alleged was an effort to deflect scrutiny from a US Attorney's office investigation of the relationship between the hospital and the practice group Midei had been a part of before signing on as staff at St Joseph.

Midei had been seeking $60 million in compensation, plus additional damages up to a maximum of $540 million.

In a separate suit, Midei is appealing the medical board's decision to repeal his license. According to Midei, the licensing decision has not yet been made.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.